A detailed history of Mutual Advisors, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Mutual Advisors, LLC holds 34,408 shares of EXEL stock, worth $1.23 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
34,408
Previous 33,518 2.66%
Holding current value
$1.23 Million
Previous $753,000 18.46%
% of portfolio
0.03%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$21.96 - $27.6 $19,544 - $24,564
890 Added 2.66%
34,408 $892,000
Q2 2024

Jul 30, 2024

SELL
$20.34 - $23.73 $166,991 - $194,823
-8,210 Reduced 19.68%
33,518 $753,000
Q1 2024

May 02, 2024

BUY
$20.17 - $23.93 $75,859 - $90,000
3,761 Added 9.91%
41,728 $990,000
Q4 2023

Jan 12, 2024

BUY
$19.25 - $24.13 $730,864 - $916,143
37,967 New
37,967 $910,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.5B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Mutual Advisors, LLC Portfolio

Follow Mutual Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Advisors, LLC with notifications on news.